Trial Profile
Phase II randomised trial of pracinostat in combination with standard-of-care in at least one haematological malignancy.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2012
Price :
$35
*
At a glance
- Drugs Pracinostat (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- Sponsors MEI Pharma
- 21 Nov 2012 New trial record